<?xml version="1.0" encoding="UTF-8"?>
<p id="Par107">Quantitative indices of EAS activation such as increases in plasma catecholamines, ACTH, AVP, and AII levels could provide valuable biomarkers by which to test whether EAS involvement explains the high mortality associated with aging and chronic disorders of regulation in COVID-19. To date, no reports have described levels of any of these compounds in COVID-19 patients. A recent correspondence noted associations of both elevated neutrophil/lymphocyte ratios and cortisol levels with decreased survival in COVID-19 patients [
 <xref ref-type="bibr" rid="CR176">176</xref>].
</p>
